0.54% | % of shares held by all insiders |
60.03% | % of shares held by institutions |
60.36% | % of float held by institutions |
88 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Rubric Capital Management LP | 13,552,997 | 30 Mar 2024 | 20.01% | 57,600,237 |
Adage Capital Partners GP L.L.C. | 9,328,739 | 30 Mar 2024 | 13.77% | 39,647,140 |
Mangrove Partners | 8,752,893 | 30 Mar 2024 | 12.92% | 37,199,795 |
Rock Springs Capital Management, LP | 8,142,109 | 30 Mar 2024 | 12.02% | 34,603,963 |
683 Capital Management LLC | 5,750,000 | 30 Mar 2024 | 8.49% | 24,437,500 |
Janus Henderson Group PLC | 5,120,573 | 30 Mar 2024 | 7.56% | 21,762,435 |
Alkeon Capital Management LLC | 4,238,100 | 30 Mar 2024 | 6.26% | 18,011,925 |
Suvretta Capital Management, LLC | 3,653,494 | 30 Mar 2024 | 5.39% | 15,527,349 |
Clearline Capital, LP | 3,326,718 | 30 Mar 2024 | 4.91% | 14,138,551 |
Soleus Capital Management, L.P. | 2,616,953 | 30 Mar 2024 | 3.86% | 11,122,050 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
abrdn Healthcare Investors | 560,468 | 30 Mar 2024 | 0.83% | 2,381,989 |
Tema ETF Tr-Tema Cardiovascular and Metabolic ETF | 371,472 | 28 Feb 2024 | 0.55% | 1,578,756 |
abrdn Life Sciences Investors | 256,841 | 30 Mar 2024 | 0.38% | 1,091,574 |
Tema ETF Tr-Tema Oncology ETF | 150,307 | 28 Feb 2024 | 0.22% | 638,804 |
Fidelity NASDAQ Composite Index Fund | 96,630 | 29 Apr 2024 | 0.14% | 410,677 |
Trust For Professional Managers-PMC Diversified Equity Fund | 55,903 | 30 Mar 2024 | 0.08% | 237,587 |
Trust for Professional Managers-ActivePassive International Equity ETF | 26,600 | 28 Feb 2024 | 0.04% | 113,050 |
John Hancock Fds II-Health Sciences Fund | 28,200 | 28 Feb 2024 | 0.04% | 119,850 |
John Hancock Var Ins Tr-Health Sciences Tr | 28,300 | 30 Mar 2024 | 0.04% | 120,275 |
EQ Advisors Trust-EQ/T. Rowe Price Health Sciences Port | 19,600 | 30 Mar 2024 | 0.03% | 83,300 |